What people are saying:

“This is literally what I have been looking foras a biomedical engineering undergrad interested in vc.”

“These are such great reads, Will!Thanks for sharing them (faster than I can read them)!”

“Will - thank you for sharing this with the Life Science Founders community. I'll make sure that our University of California, Reiverside Founders check it out.”

“This series has been awesome. Also great info for deep techfounders generally!”

“Really enjoying this book. Thank you so much!”

“Valuable resource for life scientists navigating the pathfrom research to building a startup.”

“Want”

“ It’s a great read. Congratulations!”

“A landmark resource—clear, approachable, and foundational tothe entire life science venture ecosystem.”

“What? Now I know what my beach days will look like, just theread I am thrilled about!”

“Thank you for this. I am stoked to read it. Will Alaynick we need more of this! It’s so different in life science yet there is so little
information.”

“In venture investing, timing often matters just as much as technology. That’s
why I really enjoyed Will Alaynick’s 'Venture Capital for Life
Scientists' book series — especially the chapter on Value Inflection
Points. It captures, in one clear overview, the milestones that drive value in life
sciences, diagnostics, and medtech. From a real-world perspective, what stands
out is how these paths can overlap or even compete:

- A platform technology may unlock both diagnostic andtherapeutic applications.

- Medtech and digital health often reach earlier adoption —but face reimbursement and workflow hurdles.

For investors, founders, and strategists, this kind ofmapping clarifies not just where the science is headed, but also
where capital can generate outsized impact. Seeing these inflection points
side by side is a great reminder of how interconnected — and sometimes
competing — innovation pathways can be. 👉 Highly recommend to have a read.”

“DO NOT READ this if you're NOT interested in sciencecommercialization, entrepreneurship, or venture investing in the life sciences.

Since July 29, 2025, Will Alaynick has been publishingchapters of his book (on Substack) to help life scientists, founders, and
investors gain a rich understanding of venture capital for innovations in the
life sciences.

You may or may not be in the life sciences. Regardless, youwill still find his letters resourceful (just like I do).

Out of nineteen chapters, he has so far published eleven on:

● The foundations of venture capital in life sciences

● Financial markets and investment fundamentals

● Venture capital fund structure

● Building a team for startups

● Identifying the right investors

● And others

Finally, please don't keep this information to yourself. Ifyou know someone who will find this helpful, share it with them.